Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single centerMoyuka Wada‐Irimada, Yoshihide Asano, Takehiro Takahashi et al.|The Journal of Dermatology|2025Cited by 15
Serum levels of <scp>AGGF1</scp>: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosisTakuya Takahashi, Yoshihide Asano, Takehiro Takahashi et al.|The Journal of Dermatology|2024Cited by 3
A Potential Contribution of <scp>S100A11</scp> to Skin Fibrosis and Pulmonary Involvement in Systemic SclerosisTakuya Takahashi, Yoshihide Asano, Takehiro Takahashi et al.|Experimental Dermatology|2024Cited by 2
Disseminated maculopapular drug eruption caused by ritlecitinib in a patient with alopecia areataToshiki Okazaki, Yoshihide Asano, Takehiro Takahashi et al.|European Journal of Dermatology|2025Cited by 2
<scp>IL</scp> ‐17 Signaling Inhibitors in Localized Scleroderma: A Single‐Center Case Series of Nine PatientsTakuya Takahashi, Yoshihide Asano, Takehiro Takahashi et al.|The Journal of Dermatology|2026Cited by 0